Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Addiction

• Publication date

  2012-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1360-0443.2011.03771.xPMID 22221594PMCID PMC3331916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.

  2009cited by this paper
• Treatment of obese patients with binge eating disorder using topiramate: a review

  2009cited by this paper
• Bupropion for the Treatment of Methamphetamine Dependence

  2008cited by this paper
• Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial

  2008cited by this paper
• A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.

  2008cited by this paper
• Topiramate for treating alcohol dependence: a randomized controlled trial.

  2007cited by this paper
• Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals.

  2007cited by this paper
• Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.

  2007cited by this paper
• Topiramate prevents ecstasy consumption: a case report

  2005cited by this paper
• A pilot trial of topiramate for the treatment of cocaine dependence.

  2004cited by this paper
• Prefrontal Glutamate Release into the Core of the Nucleus Accumbens Mediates Cocaine-Induced Reinstatement of Drug-Seeking Behavior

  2003cited by this paper
• Selective Antagonism of GluR5 Kainate-Receptor-Mediated Synaptic Currents by Topiramate in Rat Basolateral Amygdala Neurons

  2003cited by this paper
• Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.

  2003cited by this paper
• Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence.

  2002cited by this paper
• The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats.

  1999cited by this paper
• Structured Clinical Interview for DSM-IV Axis I Disorders

  1997cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper
• EFFECTS OF URINARY pH ON AMPHETAMINE METABOLISM

  1971cited by this paper

• Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology.

  2026cites this paper
• Association Between Psychiatric Comorbidity and Retention in Substance Use Disorder Treatment: Results From Multi-Site Randomized Controlled Trials of Pharmacological and Behavioral Interventions

  2026cites this paper
• Gender differences in the impact of psychological distress on methamphetamine use disorder outcomes and treatment effect.

  2026cites this paper
• Substance Use Disorders

  2025cites this paper
• "CL Case Conference: Managing Substance Use and Agitation in Pregnancy."

  2025cites this paper
• Acupuncture plus topiramate placebo versus topiramate plus sham acupuncture for the preventive treatment of chronic migraine: A single-blind, double-dummy, randomized controlled trial

  2024cites this paper
• A Narrative Review of the Pathophysiology and Treatment of Methamphetamine-Associated Psychosis

  2024cites this paper
• Therapeutic targeting of neuroinflammation in methamphetamine use disorder.

  2024cites this paper
• Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets

  2024cites this paper
• Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge.

  2024cites this paper
• Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorder.

  2024cites this paper
• The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.

  2024cites this paper
• Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials.

  2024cites this paper
• Selective antagonists of calcium-permeable GluA1 AMPA-receptors as potential antiaddictive agents

  2023cites this paper
• Integrative Pharmacology in the Treatment of Substance Use Disorders

  2023cites this paper
• Methamphetamine Toxicities and Clinical Management.

  2023cites this paper
• Psychosocial and pharmacologic interventions for problematic methamphetamine use: Findings from a scoping review of the literature

  2023cites this paper
• The Effectiveness of Topiramate in the Treatment of Amphetamine and Methamphetamine Use Disorder: A Randomized Controlled Trial

  2023cites this paper
• Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients

  2022cites this paper
• Narcotics Anonymous members in recovery from methamphetamine use disorder

  2022cites this paper
• Multiple comparison of different noninvasive brain stimulation and pharmacologic interventions in patients with methamphetamine use disorders: A network meta‐analysis of randomized controlled trials

  2022cites this paper
• Neuroscientific Basis of Treatment for Substance Use Disorders.

  2022cites this paper
• Patterns of reduced use and abstinence in multi-site randomized controlled trials of pharmacotherapies for cocaine and methamphetamine use disorders.

  2021cites this paper
• Pharmacotherapy treatment of stimulant use disorder

  2021cites this paper
• Pharmacotherapy treatment of stimulant use disorder

  2021cites this paper
• Effects of cytidine-5'-diphosphate choline on gray matter volumes in methamphetamine-dependent patients: A randomized, double-blind, placebo-controlled study.

  2021cites this paper
• Perinatal Methamphetamine Use: A Review of the Literature

  2021cites this paper
• Sample size re‐estimation for covariate‐adaptive randomized clinical trials

  2021cites this paper
• Treatment Response Prediction and Individualized Identification of Short-Term Abstinence Methamphetamine Dependence Using Brain Graph Metrics

  2021cites this paper
• Use of Topiramate in the Spectrum of Addictive and Eating Disorders: A Systematic Review Comparing Treatment Schemes, Efficacy, and Safety Features

  2021influential citation
• Treatment of stimulant use disorder: A systematic review of reviews

  2020cites this paper
• Pharmacotherapy of Addiction to Amphetamine-Type Stimulants

  2020cites this paper
• Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature

  2020cites this paper
• Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review

  2020cites this paper
• Efficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis

  2020cites this paper
• Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine.

  2019cites this paper
• Topiramate Pharmacotherapy for Alcohol Use Disorder and Other Addictions: A Narrative Review

  2019cites this paper
• Innovative pharmakologische Ansätze zur Behandlung von Suchterkrankungen

  2019cites this paper
• Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups

  2019influential citation
• TREATMENT OF STIMULANT USE DISORDERS: CURRENT PRACTICES AND PROMISING PERSPECTIVES

  2019cites this paper
• Validation of the Persian Version of Addiction-prone Personality Test

  2019cites this paper
• Implementing statistical methods for generalizing randomized trial findings to a target population.

  2019cites this paper
• Pharmacotherapy for Methamphetamine/Amphetamine Use Disorder - A Systematic Review and Meta-analysis.

  2019influential citation
• Effect of Topiramate on Morphine-induced Conditioned Place Preference (CPP) in Rats: Role of ERK and CREB Proteins in Hippocampus and Cerebral Cortex

  2019cites this paper
• Preclinical efficacy of an anti‐methamphetamine vaccine using E6020 adjuvant

  2019cites this paper
• Pharmacotherapy for amphetamine dependence: A systematic review.

  2018cites this paper
• The neurobiological mechanisms of physical exercise in methamphetamine addiction

  2018cites this paper
• Topiramate in the treatment of cocaine use disorder.

  2018cites this paper
• Topiramate for the Treatment of Dually Dependent on Opiates and Cocaine: A Single-center Placebo-controlled Trial

  2018cites this paper
• Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review.

  2018cites this paper
• Topiramate for the Treatment of Methamphetamine Addiction: A Meta-Analysis

  2018cites this paper
• Two New Therapies in the Cocaine-dependents: Comparison of Topiramate and Contingency Management

  2018cites this paper
• A Novel Therapy for cocaine dependence during abstinence: A randomized clinical trial

  2017cites this paper
• Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence

  2017cites this paper
• Pharmacotherapeutic agents in the treatment of methamphetamine dependence

  2017cites this paper
• Possible involvement of CREB/BDNF signaling pathway in neuroprotective effects of topiramate against methylphenidate induced apoptosis, oxidative stress and inflammation in isolated hippocampus of rats: Molecular, biochemical and histological evidences.

  2017cites this paper
• Mediatory role of NMDA, AMPA/kainate, GABAA and Alpha2 receptors in topiramate neuroprotective effects against methylphenidate induced neurotoxicity in rat

  2017cites this paper
• Evidence-Based Guidelines for the Pharmacologic Management of Methamphetamine Dependence, Relapse Prevention, Chronic Methamphetamine-Related, and Comorbid Psychiatric Disorders in Post-Acute Settings

  2017cites this paper
• CATCH : New pharmacological treatment options for crack-cocaine dependence. Results from three randomised controlled trials

  2017cites this paper
• Cognitive-Behavioural Therapies and Motivational Interviewing for Methamphetamine Use Disorders: A Systematic Review

  2017cites this paper
• Identification of Novel Signal Transduction, Immune Function, and Oxidative Stress Genes and Pathways by Topiramate for Treatment of Methamphetamine Dependence Based on Secondary Outcomes

  2017influential citation
• A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol‐Dependent Men

  2017cites this paper
• Evaluation of glutamatergic treatment in reducing nicotine seeking behavior in rats

  2017cites this paper
• Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction.

  2016cites this paper
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.

  2016cites this paper
• Topiramate for cocaine dependence: a systematic review and meta-analysis of randomized controlled trials.

  2016cites this paper
• Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial.

  2016cites this paper
• Topiramate for the management of methamphetamine dependence: a pilot randomized, double‐blind, placebo‐controlled trial

  2016cites this paper
• The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis

  2016cites this paper
• Adenosine 2A receptors modulate reward behaviours for methamphetamine

  2016cites this paper
• Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development.

  2016cites this paper
• AMPA Receptors as Therapeutic Targets for Neurological Disorders.

  2016cites this paper
• Addiction to Amphetamines and Methamphetamines

  2015cites this paper
• Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances.

  2015cites this paper
• METHAMPHETAMINE: WHERE WILL THE STAMPEDE TAKE US?

  2015cites this paper
• Clinical neuroscience of addiction: similarities and differences between alcohol and other drugs.

  2015cites this paper
• Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial

  2015cites this paper
• Recent Advances in Drug Development

  2015cites this paper
• Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine.

  2015cites this paper
• Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependence.

  2015cites this paper
• [Accuracy of the choice of the dependence syndrome treatment: evidence-based addictology against clinical practice].

  2015cites this paper
• Enduring effects of tacrine on cocaine-reinforced behavior: Analysis by conditioned-place preference, temporal separation from drug reward, and reinstatement.

  2015cites this paper
• Topiramate in Dextromethorphan Abuse

  2015cites this paper
• Recent advances in pharmacological management of substance use disorders

  2015cites this paper
• Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care.

  2015cites this paper
• Neurokinin-1 (NK₁) receptor antagonists as possible therapeutics for psychostimulant use disorders.

  2015cites this paper
• Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction

  2014cites this paper
• Pharmacological Treatment for Methamphetamine Dependence

  2014cites this paper
• an update on

  2014cites this paper
• Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.

  2014cites this paper
• [Topiramate in substance-related and addictive disorders].

  2014cites this paper
• Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial.

  2014cites this paper
• Treatment of crack-cocaine dependence with topiramate: a randomized controlled feasibility trial in The Netherlands.

  2014cites this paper
• Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.

  2014cites this paper
• Substance use in older HIV-infected patients.

  2014cites this paper
• Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature

  2014cites this paper
• The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans

  2013cites this paper
• The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans

  2013cites this paper
• The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans

  2013cites this paper
• Topiramate for the treatment of cocaine addiction: a randomized clinical trial.

  2013cites this paper